Morgan Stanley
SRTAW

Morgan Stanley’s Strata Critical Medical Inc Warrants SRTAW Stock Holding History

Morgan Stanley’s Portfolio SRTAW Stock Details SRTAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-600,419
Closed -$114K – 7980
2024
Q3 		$114K Sell
600,419
-99,581
-14% -$18.1K ﹤0.01% 5953
2024
Q2 		$118K Hold
700,000
– – ﹤0.01% 5903
2024
Q1 		$73.2K Hold
700,000
– – ﹤0.01% 6099
2023
Q4 		$245K Hold
700,000
– – ﹤0.01% 5621
2023
Q3 		$161K Hold
700,000
– – ﹤0.01% 5680
2023
Q2 		$444K Hold
700,000
– – ﹤0.01% 5279
2023
Q1 		$336K Hold
700,000
– – ﹤0.01% 5468
2022
Q4 		$350K Hold
700,000
– – ﹤0.01% 5414
2022
Q3 		$448K Hold
700,000
– – ﹤0.01% 5321
2022
Q2 		$469K Hold
700,000
– – ﹤0.01% 5456
2022
Q1 		$1.42M Hold
700,000
– – ﹤0.01% 4751
2021
Q4 		$1.55M Hold
700,000
– – ﹤0.01% 4769
2021
Q3 		$2.09M Hold
700,000
– – ﹤0.01% 4536
2021
Q2 		$1.92M Hold
700,000
– – ﹤0.01% 4665
2021
Q1 		$1.75M Buy
+700,000
New +$2.56M ﹤0.01% 4355

Other funds holding SRTAW

LP
LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return
KPF
K2 Principal Fund Toronto, Ontario, Canada $1.36B AUM 25.58% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
SCM
Saba Capital Management New York $3.9B AUM 12.9% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
TPCW
TD Private Client Wealth New York $5.44B AUM 18.56% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Morgan Stanley's SRTAW Position: Q4 2024 in Review

Morgan Stanley sold out of Strata Critical Medical Inc Warrants (SRTAW) in Q4 2024, closing a stake of 600,419 shares — an estimated $114K sold.

Morgan Stanley first reported a position in SRTAW in Q1 2021 and held it in 15 quarters. The position peaked at $2.09M in Q3 2021. 8 funds tracked by Wall St. Rank hold SRTAW as of Q4 2024.

  • Morgan Stanley reported no remaining Strata Critical Medical Inc Warrants position as of Q4 2024 after selling out during the quarter.
  • Morgan Stanley sold 600,419 Strata Critical Medical Inc Warrants shares in Q4 2024, an estimated $114K.
  • Morgan Stanley first reported a position in Strata Critical Medical Inc Warrants in Q1 2021 and held it in 15 quarters.
  • Morgan Stanley's Strata Critical Medical Inc Warrants position peaked at $2.09M in Q3 2021.
  • 8 funds tracked by Wall St. Rank held Strata Critical Medical Inc Warrants as of Q4 2024.

Based on Morgan Stanley's 13F filing for Q4 2024, filed 14 Feb 2025.